Top Markets
#1 Black Phoenix Black Phoenix +827.56%
#2 YFSX YFSX +56.32%
#3 Not in Employment, Education, or Training Not in Employment, Education, or Training +26.22%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.93%
#5 Beam Beam +23.28%
#6 SAFEcoin SAFEcoin +20.74%
#7 pipedog pipedog +18.54%
#8 Magma Finance Magma Finance +17.16%
#9 Bless Bless +16.79%
#10 THORChain THORChain +15.51%
Coin of the day
Black Phoenix Black Phoenix
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Pharvaris N.V. Pharvaris N.V.

Pharvaris N.V.

PHVS
Rang in aandelen #5604
Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the... Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist to treat attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), which is in phase 3, as well as in phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant. Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland.
Aandeelprijs
$36.83
Marktkapitalisatie
$2.57B
Verandering (1 dag)
-0.46%
Verandering (1 jaar)
54.88%
Land
NL
Handel Pharvaris N.V. (PHVS)

Categorie

Healthcare
P/S-ratio voor Pharvaris N.V. (PHVS)
P/S-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van Pharvaris N.V. is de huidige P/S-ratio (TTM) 0. Eind 2026 had het bedrijf een P/S-ratio van 0.
P/S-ratiohistoriek voor Pharvaris N.V. van 2026 tot 2026
P/S-ratio aan het einde van elk jaar
Jaar P/S-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/S-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/S-ratio Verschil in P/S-ratio Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH